Related Experiment Video
Updated: Mar 24, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.6K
Monofunctional Platinum (PtII) Compounds - Shifting the Paradigm in Designing New Pt-based Anticancer Agents
Shu Xian Chong, Steve Chik Fun Au-Yeung1, Kenneth Kin Wah To2
1Department of Chemistry, The Chinese University of Hong Kong, Sha Tin, N.T., Hong Kong SAR. scfau-yeung@cuhk.edu.hk.
Current Medicinal Chemistry
|March 12, 2016
Summary
Platinum (Pt)-based chemotherapy drugs face challenges with toxicity and resistance. Novel monofunctional Pt complexes offer a new generation of anticancer drugs by altering DNA binding and cell death pathways.
Area of Science:
- Medicinal Chemistry
- Oncology
- Molecular Biology
Background:
- Platinum (Pt)-based chemotherapy, like cisplatin, is crucial for cancer treatment but limited by toxicity and drug resistance.
- Pt drugs primarily form Pt-GG diadducts with DNA, inducing apoptosis, but interactions with proteins and metabolites cause side effects and resistance.
- Understanding these interactions is key to developing improved platinum-based anticancer agents.
Purpose of the Study:
- To review recent advancements in monofunctional platinum complexes.
- To explore the potential of these novel complexes as next-generation anticancer drugs.
- To discuss strategies for circumventing platinum resistance through tailored ligand design.
Main Methods:
- Literature review of recent developments in monofunctional platinum complexes.
- Analysis of platinum-drug interactions with DNA, proteins, and metabolites.
- Evaluation of alternative cell death mechanisms induced by modified platinum compounds.
Main Results:
- Monofunctional Pt complexes offer a different mode of DNA binding compared to traditional Pt drugs.
- Tailored ligand design can fine-tune the electronic properties of Pt compounds.
- Altered binding may lead to alternative cancer cell death pathways, potentially overcoming resistance.
Conclusions:
- Monofunctional platinum complexes represent a promising new direction in anticancer drug development.
- Carefully designed ligands can mitigate toxicity and overcome drug resistance.
- These novel complexes hold potential for a new generation of platinum-based cancer therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:52Stereoisomerism
14.5K
Isomerism in Complexes
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
14.5K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
66
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66